Lawyers for former Nissan Motor Co chairman Carlos Ghosn submitted filings to the Tokyo District Court on Thursday seeking the dismissal of all charges against him and accusing Japanese officials and executives at the automaker of collusion.
Oct.23 — Sanjeev Rana, senior analyst at CLSA, discusses SK Hynix earnings and they mean for the chip sector. He speaks on “Bloomberg Daybreak: Asia.” …read more […]
Oil prices dipped on Thursday on lingering concerns about a weak demand outlook, after surging more than 2% in the previous session on the back of a surprise draw in U.S. crude stocks.
U.S. gold futures was flat at $1,494.60 per ounce. * EU member states on Wednesday delayed a decision on whether to grant Britain a three-month Brexit extension, while Prime Minister Boris Johnson said if the deadline is deferred to the end of January he would call an election by Christmas. * Asian shares pulled ahead on Thursday with corporate earnings buffeting trading as investors remained anxious about the business impact of the Sino-U.S. trade war while Brexit uncertainties kept overall sentiment in check. …read more […]
Q4 2019 TD Ameritrade Holding Corp Earnings Call …read more […]
Asian shares pulled ahead on Thursday with corporate earnings buffeting trading as investors remained anxious about the business impact of the Sino-U.S. trade war while Brexit uncertainties kept overall sentiment in check.
Snap Inc said on Wednesday that the U.S Department of Justice and the Securities and Exchange Commission were no longer investigating whether the company misled investors at the time of its March 2017 initial public offering.
GlaxoSmithKline said U.S. regulators had approved its ovarian cancer treatment Zejula for wider use in some advanced cancers, in a boost to the British drugmaker’s oncology portfolio as it competes with rival AstraZeneca. The U.S. Food and Drug Administration approval is for the drug’s use in advanced ovarian, fallopian tube, or primary peritoneal cancer patients who have undergone at least three prior chemotherapy regimens and whose disease has come back. Zejula is currently approved as a maintenance therapy for adults with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer and whose tumours have completely or partially responded …read more […]
How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies. However, an easier way is to look at the stocks that smart money investors are collectively bullish on. Hedge funds and other institutional investors usually invest large amounts of […] …read more […]
NEW YORK/BOSTON, Oct 23 (Reuters) – Teva Pharmaceutical Industries Ltd’s proposed $23 billion drug giveaway to settle thousands of U.S. opioid lawsuits will likely cost the company a fraction of that figure due to how it has valued those medicines, according to a Reuters review of pricing data and industry analysts. When Teva announced the value of the donated medicine – a generic version of opioid addiction treatment Suboxone – it based the figure on the drug’s list price, which does not account for significant discounts routinely provided by the drugmaker. If based on the estimated cost to …read more […]
The recent truce in the U.S.-China trade war is not an economic turning point and has done nothing to reduce a significant risk that the United States could slip into recession in the next two years, a Reuters poll of economists found.
(Bloomberg Opinion) — China’s $13 trillion bond market seems calmer this year, with fewer defaults than 2018. Underneath the surface, though, is a churning current that threatens to swallow investors who aren’t careful.The case of Xiwang Group Co. is one such cautionary tale. Just days ago, this distressed industrial conglomerate in the northeast province of Shandong thought it could borrow for peanuts. The company, whose business operations span corn-oil processing to steel manufacturing, tried to raise 450 million yuan ($63.5 million) at a coupon range of 7.5% to 8.5%. The deal was scrapped Wednesday. Meanwhile, the company warned in a …read more […]
U.S. Trade Representative Robert Lighthizer met this week with Democratic lawmakers to try to resolve their concerns about the U.S.-Mexico-Canada (USMCA) trade agreement as Republicans increased pressure to get the deal passed by the end of 2019.
Q3 2019 Veracyte Inc Earnings Call …read more […]
Legendary investors such as Jeffrey Talpins and Seth Klarman earn enormous amounts of money for themselves and their investors by doing in-depth research on small-cap stocks that big brokerage houses don’t publish. Small cap stocks -especially when they are screened well- can generate substantial outperformance versus a boring index fund. That’s why we analyze the […] …read more […]
Copyright 1997-2019 Wall Street Reporter / Octagon Media Corp.
